CHDI’s goal is to increase the understanding of Huntington’s disease (HD) and to hasten the development of therapies.We collaborate with academic and industrial scientists throughout the world.
This website highlights activities that may be of particular interest to people engaged in or contemplating HD research and provides information on targets, compounds, and research materials that HD researchers may find useful.
Please join our mailing list
News Headlines
-
05/14/2012
KineMed and CHDI Foundation announce collaboration
KineMed, Inc. and CHDI Foundation, Inc. collaborate to develop new biomarkers of disease progression and to evaluate potential therapeutics for Huntington's disease.
-
09/06/2011
CHDI Foundation appoints new Chief Clinical Officer
CHDI Foundation, Inc. has appointed Cristina Sampaio, MD, PhD to the newly-created position of Chief Clinical Officer.
Upcoming Scientific Events
-
February 27- March 1, 2012
7th Annual HD Therapeutics Conference
The Parker Hotel, Palm Springs, CA

